Doctor of Osteopathy Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Daniel Beauchamp

Physical Medicine & Rehabilitation Apo, AE Doctor of Osteopathy

NPI 1336458207 CMS profile 151168

Unit 33100 Box Landstuhl, Apo, AE 09180

Open in the dashboard

General payments

$112,512

106 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Daniel Beauchamp of Apo, AE is reported in the CMS Open Payments database as having received $112,512 across 106 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $26,705 14
2023 General $49,664 33
2022 General $34,352 35
2021 General $953 13
2020 General $617 8
2019 General $220 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Beauchamp
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Daniel Beauchamp were reported at $0. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Daniel Beauchamp Physical Medicine & Rehabilitation median Middle half National median
2019 $220 $133 $45–$390 $163
2020 $617 $88 $29–$272 $114
2021 $953 $116 $33–$360 $132
2022 $34,352 $123 $40–$378 $149
2023 $49,664 $131 $43–$396 $160
2024 $26,705 $141 $45–$409 $164
2025 $0 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Kedplasma LLC $108,236 57 payments
  2. Abbott Laboratories $1,687 21 payments
  3. Relievant Medsystems, Inc. $901 6 payments
  4. Nevro Corp. $381 3 payments
  5. Boston Scientific Corporation $313 4 payments
  6. Medtronic USA, Inc. $266 6 payments
  7. Medtronic, Inc. $231 4 payments
  8. Saluda Medical Americas, Inc. $148 1 payment
  9. Allergan Inc. $119 1 payment
  10. Nalu Medical, Inc. $114 1 payment
  11. Other $115 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $108,236 57 payments
  2. Food and Beverage $2,778 41 payments
  3. Travel and Lodging $1,498 8 payments
Products named General payments · program years 2019–2024
  1. PROCLAIM Neuromodulation $968 8 payments
  2. Intracept Pain $901 6 payments
  3. Intracept Pain $901 6 payments
  4. Senza Spinal Cord Stimulation System $381 3 payments
  5. PROCLAIM Neuromodulation $330 6 payments
  6. Proclaim IPG $323 6 payments
  7. Superion $242 3 payments
  8. KYPHON Balloon Kyphoplasty $217 4 payments
  9. ECAP Study $148 1 payment
  10. BOTOX $119 1 payment
  11. Other $623 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

106 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physical Medicine & Rehabilitation in Armed Forces Europe

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record